CCS
BHC icon

Crosspoint Capital Strategies’s Bausch Health BHC Stock Holding History

Crosspoint Capital Strategies’s Portfolio BHC Stock Details BHC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q3 		– Sell
-202
Closed -$45K – 765
2015
Q2 		$45K Buy
+202
New +$44.8K 0.01% 357
2015
Q1 		– Sell
-101
Closed -$14K – 531
2014
Q4 		$14K Buy
+101
New +$13.6K ﹤0.01% 479
2014
Q2 		– Sell
-39,360
Closed -$5.19M – 520
2014
Q1 		$5.19M Buy
39,360
+331
+0.8% +$45.3K 2.1% 20
2013
Q4 		$5.71M Buy
+39,029
New +$4.28M 1.9% 24

Other funds holding BHC

RCG
Ruane, Cunniff & Goldfarb New York $6.03B AUM 12.06% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
PSCM
Pershing Square Capital Management New York $13.7B AUM 13.45% 1-Year Est. Return
VH
ValueAct Holdings San Francisco, California $5.71B AUM 7.41% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
PC
Paulson & Co New York $3.11B AUM 94.93% 1-Year Est. Return
Grantham, Mayo, Van Otterloo & Co (GMO)
Grantham, Mayo, Van Otterloo & Co (GMO) Boston, Massachusetts $39.1B AUM 28.69% 1-Year Est. Return
LPC
Lone Pine Capital Greenwich, Connecticut $12.5B AUM 54.4% 1-Year Est. Return
Bank of Montreal
Bank of Montreal Toronto, Ontario, Canada $269B AUM 31.4% 1-Year Est. Return

Crosspoint Capital Strategies's BHC Position: Q3 2015 in Review

Crosspoint Capital Strategies sold out of Bausch Health (BHC) in Q3 2015, closing a stake of 202 shares — an estimated $45K sold.

Crosspoint Capital Strategies first reported a position in BHC in Q4 2013 and held it in 4 quarters. The position peaked at $5.71M in Q4 2013. 546 funds tracked by Wall St. Rank hold BHC as of Q3 2015.

  • Crosspoint Capital Strategies reported no remaining Bausch Health position as of Q3 2015 after selling out during the quarter.
  • Crosspoint Capital Strategies sold 202 Bausch Health shares in Q3 2015, an estimated $45K.
  • Crosspoint Capital Strategies first reported a position in Bausch Health in Q4 2013 and held it in 4 quarters.
  • Crosspoint Capital Strategies's Bausch Health position peaked at $5.71M in Q4 2013.
  • 546 funds tracked by Wall St. Rank held Bausch Health as of Q3 2015.

Based on Crosspoint Capital Strategies's 13F filing for Q3 2015, filed 25 Nov 2015.